Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abiomed bids to buy out partnership:

This article was originally published in Clinica

Executive Summary

Abiomed has offered to pay $10,000 per unit for each of the 135 outstanding units of the Abiomed Limited Partnership. If accepted, the offer will reduce or eliminate the company's royalty obligations on sales of its BVS-5000 and SupraCor temporary cardiac support systems. The original annual royalty of 5.5% on product revenues has already been reduced to 4.9% through a 10.9% ownership in the limited partnership. The limited partners have until July 25th, 1995, to accept the offer.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel